Showing results (101-110 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|March 26, 2013
No changes in striatal dopamine transporter in antidepressant-treated patients with major depressionCheng-Kuan Wu, Kao Chin Chen, Po See Chen, et al.International Clinical Psychopharmacology|January 1, 1997
Citalopram as an adjuvant in schizophrenia: further evidence for a serotonergic dimension in schizophreniaT J Taiminen, E Syvälahti, S Saarijärvi, et al.International Clinical Psychopharmacology|January 1, 1997
Mianserin and restless legsJ Markkula, H LauermaInternational Clinical Psychopharmacology|March 14, 2002
Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depressionJ M Ferguson, J Mendels, G E SchwartInternational Clinical Psychopharmacology|May 1, 2002
The adequacy of pharmacotherapy in outpatients with obsessive-compulsive disorderD Denys, H Van Megen, H WestenbergInternational Clinical Psychopharmacology|May 1, 2002
Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled studyM Atmaca, M Kuloglu, E Tezcan, et al.International Clinical Psychopharmacology|November 1, 1993
The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disordersR M Salomon, H L Miller, P L Delgado, et al.International Clinical Psychopharmacology|May 1, 1997
What are the therapeutic needs in schizophrenia and how are they satisfied by new antipsychotics?J M KaneInternational Clinical Psychopharmacology|March 1, 1997
The role of antipsychotic agents in the treatment of bipolar disorder patientsJ C Soares, A G Mallinger, S GershonInternational Clinical Psychopharmacology|March 1, 1997
Long-term treatment of depression: is there a use for depot antidepressants?P Baumann, G BertschyPageof 212